Acurx Pharmaceuticals, Inc. (ACXP)
1.875
-0.06
(-3.35%)
USD |
NASDAQ |
May 15, 12:06
Acurx Pharmaceuticals EPS Diluted (Quarterly) : -0.6184 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Quince Therapeutics, Inc. | 3.908 |
| Lantern Pharma, Inc. | -0.362 |
| Sensei Biotherapeutics, Inc. | -3.622 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.681M |
| Total Expenses (Quarterly) | 1.681M |
| Enterprise Value | -4.314M |
| Earnings Yield | -234.9% |
| Normalized Earnings Yield | -234.85 |